[Research Report] The metabolomics services market is expected to reach US$ 1,895.14 million by 2028 from US$ 501.24 million in 2021; it is estimated to grow at a CAGR of 20.9% from 2021 to 2028.
Metabolomics is the study and analysis of biological processes involving metabolic intermediates and byproducts—metabolomes. The metabolomes include secondary metabolites, signaling molecules, hormones, and metabolic intermediates.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Metabolomics Services Market: Strategic Insights
Market Size Value in US$ 501.24 million in 2021 Market Size Value by US$ 1,895.14 million by 2028 Growth rate CAGR of 20.9% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Metabolomics Services Market: Strategic Insights
| Market Size Value in | US$ 501.24 million in 2021 |
| Market Size Value by | US$ 1,895.14 million by 2028 |
| Growth rate | CAGR of 20.9% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The report offers an in-depth analysis of the metabolomics services market, emphasizing on market trends, technological advancements, market dynamics, and competitive landscape (involving major market players across the world). It also includes the impact of the COVID-19 pandemic on the market across all the major regions. North America holds the largest market share, and the market growth in this region is attributed to high awareness and acceptance for metabolomics services, increasing number of online retails, and rising number of product innovations and launches. Moreover, the growing spending by sex technology companies are also likely to have positive impact on the North America metabolomics services market during the forecast period. The market, by region, is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SAM).
Lucrative Regions for Metabolomics Services Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Incidences of Cancer Fuels Metabolomics Services Market Growth
Metabolomics is among the growing and robust technologies for detecting a wide range of metabolites in tissues and biofluids. This process has a significant application in the analysis and studies associated with cancer disease. The rising prevalence of different types of cancer is expected to drive the market during the forecast period. Cancer diagnostics play an essential role in cancer treatment. As per the data published by the World Health Organization (WHO) in September 2021, nearly 70% of deaths from cancer were reported from the low- and middle-income countries across the globe. The total global share of cancer incidence share as per the Global Cancer Observatory records are breast (2.26 million cases 11.7%), lung (2.21 million cases 11.4%), colon and rectum (1.93 million cases 10%), prostate (1.41 million cases 7.3%), stomach (1.09 million cases 5.6%). Below are the details regarding the regional prevalence in 2020:
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Service Type-Based Insights
The metabolomics services market, based on service type, has been segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold a larger market share in 2021. Moreover, the targeted metabolomics service segment is anticipated to register a higher CAGR in the market during the forecast period.
Metabolomics Services Market, by Service Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Insights
The metabolomics services market, based on application, is segmented into pharmaceutical and biotechnology industry, agritech, and environment. The pharmaceutical and biotechnology industry segment is likely to hold the largest share of the market in 2021. Moreover, the market for this segment is expected to grow at the fastest CAGR of 21.6% during 2021 to 2028.
The metabolomics services market players adopt organic strategies such as product launch and expansion to expand their global footprint and product portfolio.
By Service Type
- Targeted Metabolomics Service
- Untargeted Metabolomics Service
By Application
- Pharmaceutical and Biotechnology Industry
- Biomarker Discovery
- Drug Discovery
- Toxicological Testing
- Others
- Agritech
- Environment
By
Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
- Afekta Technologies Ltd.
- Fred Hutchinson Cancer Research Center
- West Coast Metabolomics Center
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Service Type and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
BASF SE and TMIC .are the key players in the Metabolomics Services market
Targeted metabolomics service segment market provides the most opportunity for growth
The Metabolomics Services market is anticipated to grow around 20.9% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2021.
Key factors that are driving growth of the market are rising incidences of cancer and increasing adoption of metabolomics and investments by market players. However, high cost of tools, instruments, and usage is expected to restrict the market growth during the forecast period.
Metabolomics is the study and analysis of biological processes involving metabolic intermediates and byproducts. These products are referred to as metabolomes, and they contain all metabolites involved in an organism's many processes, including secondary metabolites, signalling molecules, hormones, and metabolic intermediates.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Metabolomics Services Market – By Service Type
1.3.2 Global Metabolomics Services Market – By Application
1.3.3 Global Metabolomics Services Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Metabolomics Services Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Metabolomics Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Cancer
5.1.2 Increasing Adoption of Metabolomics and Investments by Market Players
5.2 Market Restraints
5.2.1 High Cost of Tools, Instruments, and Usage
5.3 Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
5.5 Impact Analysis
5.6 Opportunities for Contract Research (CR)
5.7 Opportunities for Supplies of Consumables
5.8 Opportunities for Commercialization of Disease Biomarkers
6. Metabolomics Services Market– Global Analysis
6.1 Global Metabolomics Services Market Revenue Forecast and Analysis
6.2 Global Metabolomics Services Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Metabolomics Services Market Revenue and Forecasts To 2028– by Service Type
7.1 Overview
7.2 Global Metabolomics Services Market, By Service Type 2021 & 2028 (%)
7.3 Targeted Metabolomics Service
7.3.1 Overview
7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Untargeted Metabolomics Service
7.4.1 Overview
7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8. Metabolomics Services Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Global Metabolomics Services Market Share by Application 2021 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Industry
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.1 Biomarker Discovery
8.3.2.1.1 Overview
8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.2 Toxicological Testing
8.3.2.2.1 Overview
8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.3 Drug Discovery
8.3.2.3.1 Overview
8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.4 Others
8.3.2.4.1 Overview
8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Agritech
8.4.1 Overview
8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Environment
8.5.1 Overview
8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9. Metabolomics Services Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 North America: Metabolomics Services Market
9.1.1 Overview
9.1.2 North America: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.3 North America: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)
9.1.4 North America: Metabolomics Services Market, by Application, 2019–2028 (USD Million)
9.1.4.1 North America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)
9.1.5 North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1.1 US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1.2 US: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)
9.1.5.1.3 US: Metabolomics Services Market, by Application, 2019–2028 (USD Million)
9.1.5.1.3.1 US: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)
9.1.5.2 Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2.1 Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2.2 Canada: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)
9.1.5.2.3 Canada: Metabolomics Services Market, by Application, 2019–2028 (USD Million)
9.1.5.2.3.1 Canada: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)
9.1.5.3 Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.3.1 Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.3.2 Mexico: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)
9.1.5.3.3 Mexico: Metabolomics Services Market, by Application, 2019–2028 (USD Million)
9.1.5.3.3.1 Mexico: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)
9.2 Europe: Metabolomics Services Market
9.2.1 Overview
9.2.2 Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.4 Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.2.4.1 Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.2.5 Europe: Metabolomics Services Market, by Country, 2021 & 2028(%)
9.2.5.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.1.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.1.2 Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.5.1.3 Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.2.5.1.3.1 Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.2.5.2 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.2.1 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.2.2 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.5.2.3 France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.2.5.2.3.1 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.5.3 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.1 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.2 UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.3 UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.2.5.3.3.1 UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.2.5.4 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.1 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.2 Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.3 Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.2.5.4.3.1 Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.2.5.5 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.1 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.2 Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.3 Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.2.5.5.3.1 Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.2.5.6 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.1 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.2 Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.3 Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.2.5.6.3.1 Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.3 Asia Pacific Metabolomics Services Market Revenue and Forecasts To 2028
9.3.1 Overview
9.3.2 Asia Pacific Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.4 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.4.1 Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.3.5 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
9.3.5.1 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.1.1 Overview
9.3.5.1.2 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.1.3 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.1.4 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.1.4.1 Japan: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.3.5.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.2.1 Overview
9.3.5.2.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.2.3 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.2.4 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.2.4.1 . China: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.3.5.3 India Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.3.1 Overview
9.3.5.3.2 India: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.3.3 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.3.4 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.3.4.1 India: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.3.5.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.4.3 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.4.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.4.4.1 South Korea: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.3.5.5 Australia: Metabolomics Services Market Revenue and Forecasts to 2028(US$ Mn)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5.5.3 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.5.4 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.5.4.1 Australia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.3.5.6 Rest of Asia Pacific: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia Pacific: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.5.6.3 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.3.5.6.4 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.3.5.6.4.1 Rest of Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.4 Middle East & Africa Metabolomics Services Market Revenue and Forecasts To 2028
9.4.1 Overview
9.4.2 Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.3 Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.4.4.1 Middle East & Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.4.5 Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
9.4.5.1 UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.1.1 Overview
9.4.5.1.2 UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.1.3 UAE: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.1.4 UAE: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.1.4.1 UAE: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.4.5.2 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.2.1 Overview
9.4.5.2.2 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.2.3 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.2.4 Saudi Arabia: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.2.4.1 Saudi Arabia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.4.5.3 South Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.3.1 Overview
9.4.5.3.2 South Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.3.3 South Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.3.4.1 South Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.4.5.4 Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.4.5.4.3 Rest of Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.4.5.4.4.1 Rest of Middle East and Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.5 South And Central America Metabolomics Services Market Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.3 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
9.5.4 South and Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.5.4.1 South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.5.5 South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
9.5.5.1 Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.1.1 Overview
9.5.5.1.2 Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.1.3 Argentina Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
9.5.5.1.4 Argentina: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.5.5.1.4.1 Argentina: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.5.5.2 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.2.1 Overview
9.5.5.2.2 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.5.5.2.3 Brazil: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.5.5.2.4 Brazil: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.5.5.2.4.1 Brazil: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.5.5.3 Rest of South and Central America: Metabolomics Services Market– Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South and Central America: Metabolomics Services Market– Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.3 Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
9.5.5.3.4 Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts To 2028, By Application (US$ Mn)
9.5.5.3.4.1 Rest of South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Metabolomics Services Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Metabolomics Services Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 BASF SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 TMIC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Proteomics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BGI
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 RTI International
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Afekta Technologies Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Fred Hutchinson Cancer Research Center
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 West Coast Metabolomics Center
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Molecular You
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Metabolon, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 biocrates life sciences ag
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Chenomx Inc.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 C-CAMP
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 metaSysX
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 MS-Omics
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceutical Companies
Table 2. North America Metabolomics Services Market, by Service Type– Revenue and Forecast to 2028 (USD Million)
Table 3. North America Metabolomics Services Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry– Revenue and Forecast to 2028 (USD Million)
Table 5. US Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. US Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. US Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 14. Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 17. Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 20. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 21. France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 22. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 23. UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 24. UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 25. UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 26. Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 28. Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 29. Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 36. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 37. Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 38. Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 39. Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 40. Japan: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 41. China: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 42. China: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 43. China: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 44. India: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 45. India: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 46. India: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 48. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 49. South Korea: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 50. Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 51. Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 52. Australia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 54. Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 55. Rest of Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 56. Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 57. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 58. Middle East & Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 59. UAE: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 60. UAE: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 61. UAE: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 62. Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 63. Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 64. Saudi Arabia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 65. South Africa Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 66. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 67. South Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 68. Rest of Middle East & Africa: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 69. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 70. Rest of Middle East and Africa: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
Table 72. South and Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 73. South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 74. Argentina Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
Table 75. Argentina: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 76. Argentina: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 78. Brazil: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 79. Brazil: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type(US$ Mn)
Table 81. Rest of South & Central America: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 82. Rest of South and Central America: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 83. organic Developments Done By Companies
Table 84. Inorganic Developments Done By Companies
Table 85. Glossary of Terms, Metabolomics Services Market
LIST OF FIGURES
Figure 1. Metabolomics Services Market Segmentation
Figure 2. Metabolomics Services Market, By Region
Figure 3. Global Metabolomics Services Market Overview
Figure 4. Silicone Segment Held Largest Share of Type Segment in Metabolomics Services Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Metabolomics Services Market, by Geography (US$ Million)
Figure 7. Global Metabolomics Services Market- Leading Country Markets (USD Million)
Figure 8. Global Metabolomics Services Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East And Africa : PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Metabolomics Services Market
Figure 16. Global Metabolomics Services Market– Revenue Forecast and Analysis – 2021- 2028
Figure 17. Global Metabolomics Services Market– By Geography Forecast and Analysis – 2021- 2028
Figure 18. Market Positioning of Key Players in Global Metabolomics Services Market
Figure 19. Global Metabolomics Services Market, by Service Type 2021 & 2028 (%)
Figure 20. Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Global Metabolomics Services Market Share by Application 2021 & 2028 (%)
Figure 23. Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 25. Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 29. Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 30. North America: Metabolomics Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 31. North America Metabolomics Services Market Revenue and Forecast to 2028 (USD Million)
Figure 32. North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 33. US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Europe: Metabolomics Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. Europe: Metabolomics Services Market Revenue and Forecast to 2028 (USD Million)
Figure 38. Europe: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Asia Pacific Metabolomics Services Market Overview, by Country (2021)
Figure 46. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
Figure 48. Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 50. India: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 51. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 52. Australia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 53. Rest of Asia Pacific: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. Middle East & Africa Metabolomics Services Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 55. Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 56. Middle East & Africa Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
Figure 57. UAE: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 58. Saudi Arabia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 59. South Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 60. Rest of Middle East and Africa: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 61. South and Central America Metabolomics Services Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 62. South and Central America Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 63. South and Central America Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
Figure 64. Argentina Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 65. Brazil: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 66. Rest of South and Central America: Metabolomics Services Market– Revenue and Forecast to 2028 (USD Mn)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 71. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 72. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Metabolomics Services Market
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
- Afekta Technologies Ltd.
- Fred Hutchinson Cancer Research Center
- West Coast Metabolomics Center
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Metabolomics Services Market
Oct 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Oct 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Oct 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Oct 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Oct 2021